A Global Survey of Mental Health Treatment Experiences among Food Allergy Patients and Caregivers

Abstract

BACKGROUND: Barriers to mental health treatment have been identified among individuals managing food allergy (FA), yet little is known about their experiences accessing this care. OBJECTIVE: We assessed the mental health treatment experiences of caregivers and adults with FA within the Global Access to Psychological Services for FA Study. METHODS: Caregivers of children with FA and adults with FA from >20 countries completed online surveys about experiences with FA-related mental health treatment. RESULTS: Overall, 21.6% (411/1907) of caregivers and 22.8% (304/1329) of adults reported receiving FA-related mental health treatment. Most of those participants (96.2%) lived in Australia, Brazil, Canada, France, Germany, Italy, Portugal, Spain, the United Kingdom, or the United States. Cognitive behavioral therapy was the most common treatment reported by caregivers (30.1%) and adults (33.2%). Most caregivers and adults were at least somewhat satisfied with their experience (75.9% and 72.4%, respectively) and perceived that mental health providers were at least somewhat FA knowledgeable (62.5% and 60.06%, respectively), although caregiver and adult perceptions of knowledge significantly varied by country with lowest percentages in Australia (31.8% and 33.4%, respectively) and highest in Portugal (96.0% and 90.9%, respectively), p<.01. Most caregivers (72.1%) and adults (75.0%) reported mental health providers were at least somewhat helpful at addressing FA concerns, albeit again with significant international differences, p<.01. CONCLUSIONS: Most caregivers and adults reported satisfaction with FA-related mental health treatment and believed providers were somewhat FA knowledgeable. However, inter-country attitudes about FA-related mental health treatment experiences were noted.

Publication DOI: https://doi.org/10.1016/j.jaip.2025.05.015
Divisions: College of Health & Life Sciences > School of Psychology
Funding Information: Funding for this project was awarded by Novartis, Aimmune, National Peanut Board and EAACI.
Additional Information: Copyright © 2025. This accepted manuscript version is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International https://creativecommons.org/licenses/by-nc-nd/4.0/
Publication ISSN: 2213-2198
Last Modified: 27 May 2025 14:06
Date Deposited: 27 May 2025 14:06
Full Text Link:
Related URLs: https://www.cli ... Dtrue&referrer= (Publisher URL)
PURE Output Type: Article
Published Date: 2025-05-14
Published Online Date: 2025-05-14
Accepted Date: 2025-05-06
Authors: Herbert, Linda Jones
Knibb, Rebecca C (ORCID Profile 0000-0001-5561-0904)
Protudjer, Jennifer L.P.
Jones, Christina J
Marchisotto, Mary Jane
Brough, Helen A
Warren, Christopher
Screti, Cassandra
Engel, Melissa L
Park, Sean
Santos, Alexandra F
Gupta, Ruchi
Vickery, Brian P

Download

[img]

Version: Accepted Version

Access Restriction: Restricted to Repository staff only until 14 May 2026.

License: Creative Commons Attribution Non-commercial No Derivatives


Export / Share Citation


Statistics

Additional statistics for this record